- £75.59bn
- £90.25bn
- £32.67bn
Factbox: Major drugmakers turn to China for licensing deals
Director/PDMR Shareholding
Pennsylvania says GSK to invest more than $800 million in biopharma hub, create 300 jobs
Wendy Becker CBE - New Directorship
Factbox: Major drugmakers turn to China for licensing deals
Factbox: Major drugmakers turn to China for licensing deals
Brief: Wave Life Sciences Announces Gsk’S Selection Of Sirna Program To Transition To Gsk For Further Development
Hutchmed Climbs After On Initiating Hmpl: A830 global trial in solid tumors
Director/PDMR Shareholding
Brief: GSK's Jemperli (Dostarlimab) Accepted For Review By Health Canada
Director/PDMR Shareholding
European drugmakers call for faster trials, more spending to compete with US, China
Brief: GSK Canada & Pan-Canadian Pharmaceutical Alliance Sign LOI For Blenrep For A Type Of Multiple Myeloma
Europe Research Roundup: GSK, Schott Pharma, Vodafone
UK Stocks-Factors to watch on September 15 (updated)
GSK strikes up to $750 million deal for cancer-targeting drug (updated)
GSK strikes up to $750 million deal for cancer-targeting drug
GSK to acquire T cell-engager for multiple myeloma
GSK gains after positive results for two lung cancer drugs